I would definitely concur with both of those statements. I think being refundable would be valuable, even with the caveat of it being reinvested back into R and D.
The tracking is certainly a piece of work, and just the interpretation required.... I think it's an evolving body of knowledge to understand what should be qualified, and the record keeping. If there were some changes or ways to facilitate that in a better way, it would help.